BILL & MELINDA GATES MEDICAL RESEARCH INSTITUTE (EIN 821808476) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2017

Legal Domicile

Principal Officer

HARISH KAUSHAL

Phone

8577022108

Tax Period

2023-01-01 to 2023-12-31

BILL & MELINDA GATES MEDICAL RESEARCH INSTITUTE, founded in 2017, is a major nonprofit in the Health Care sector that reported $809.5M in total revenue in fiscal year 2023. Revenue surged 6469% from the prior year, signaling strong growth momentum. The organization ran a surplus of $619.8M, a strong 77% operating margin.

Mission

THE GATES MRI ENGAGES DIRECTLY IN THE CONDUCT OF MEDICAL RESEARCH IN CONJUNCTION WITH ONE OR MORE HOSPITALS FOR THE PURPOSE OF ADDRESSING MAJOR CAUSES OF ILLNESS AND DEATH IN LOW-AND LOWER-MIDDLE-INCOME COUNTRIES.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $809,272,816

Program Service Revenue $0

Investment Income $183,048

Other Revenue $3,783

TOTAL REVENUE $809,459,647

Expense Breakdown

Grants Paid $0

Salaries & Benefits $58,425,016

Fundraising Expenses $0

Program Expenses $172,497,260

Other Expenses $131,188,138

TOTAL EXPENSES $189,613,154

Year-over-Year Comparison

	2023	2022	Change
Revenue	$809,459,647	$12,321,803	+64.7%
Expenses	$189,613,154	$137,217,184	+0.4%
Net Income	$619,846,493	$-124,895,381	-6.0%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✓ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

N/A

Employees

172

Volunteers

N/A

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$2,183,706

Total Directors

$3,635,515

Key Employees

$2,841,500

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
TREVOR MUNDEL	DIRECTOR, BOARD CHAIR	3.00	Director	$0	$75,958	$1,425,164
CAROLYN AINSLIE	DIRECTOR	2.00	Director	$0	$78,876	$1,055,423
TONI HOOVER	DIRECTOR	2.00	Director	$0	$78,033	$666,113
GAGANDEEP KANG	DIRECTOR (START 10/18/2023)	2.00	Director	$0	$60,196	$487,832
HELENE MADONICK	DIRECTOR	2.00	Director	$0	$0	$983
EMILIO EMINI	CHIEF EXECUTIVE OFFICER	40.00	Officer	$825,711	$74,069	$899,780
MAHENDRA PATTNI	TREASURER (END 11/28/2023)	40.00	Officer	$535,156	$89,346	$624,502
SALLY JENNINGS	SECRETARY	40.00	Officer	$426,910	$81,699	$508,609
HARISH KAUSHAL	TREASURER (START 11/28/2023)	40.00	Officer	$127,240	$23,575	$150,815
MICHAEL DUNNE	CHIEF MEDICAL OFFICER, HEAD OF DEVELOPMENT	40.00	Key Emp	$763,134	$92,474	$855,608
DEBRA WEISS	CHIEF OPERATING OFFICER	40.00	Key Emp	$629,417	$77,773	$707,190
PIPER TRELSTAD	HEAD OF CHEMISTRY, MANUFACTURING & CONTROLS	40.00	Key Emp	$589,718	$88,698	$678,416
JARED SILVERMAN	HEAD OF TRANSLATIONAL DISCOVERY	40.00	Key Emp	$509,658	$90,628	$600,286
JAMES HULEATT	BIOASSAY DEVELOPMENT LEAD	40.00	Highest	$497,303	$85,390	$582,693
CHARLES WELLS	HEAD OF THERAPEUTICS DEVELOPMENT	40.00	Highest	$496,164	$76,056	$572,220
ALEXANDER SCHMIDT	HEAD OF VACCINE DEVELOPMENT	40.00	Highest	$479,216	$90,501	$569,717
MARLA CURRAN	HEAD OF BIOSTATISTICS & DATA SCIENCE	40.00	Highest	$462,582	$91,298	$553,880
LUISA STAMM	CLINICAL DEVELOPMENT LEADER	40.00	Highest	$463,616	$86,031	$549,647
TARYN ROGALSKI-SALTER	HEAD OF GLOBAL REGULATORY STRATEGY	0.00		$351,238	$48,423	$399,661

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$809,459,647	$189,613,154	$816,974,806	$619,846,493
2022	$12,321,803	$137,217,184	$186,459,426	$-124,895,381
2021	$216,748,532	$105,126,022	$277,647,725	$111,622,510
2020	$32,100,737	$99,371,314	$171,367,184	$-67,270,577
2019	$9,807,864	$41,227,552	$219,318,998	$-31,419,688
2018	$9,822,484	$22,373,638	$248,840,285	$-12,551,154

BILL & MELINDA GATES MEDICAL RESEARCH INSTITUTE